Novo Nordisk A/S (NOVO-B.CO)

DKK 771.6

(0.22%)

Eps Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual eps in 2023 was 18.67 DKK , down -23.83% from previous year.
  • Novo Nordisk A/S's latest quarterly eps in 2024 Q2 was 4.50 DKK , down -21.05% from previous quarter.
  • Novo Nordisk A/S reported an annual eps of 24.51 DKK in 2022, up 17.89% from previous year.
  • Novo Nordisk A/S reported an annual eps of 20.79 DKK in 2021, up 15.18% from previous year.
  • Novo Nordisk A/S reported a quarterly eps of 5.70 DKK for 2024 Q1, up 15.85% from previous quarter.
  • Novo Nordisk A/S reported a quarterly eps of 8.65 DKK for 2023 Q2, down -1.82% from previous quarter.

Annual Eps Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Eps of Novo Nordisk A/S (2023 - 1989)

Year Eps Eps Growth
2023 18.67 DKK -23.83%
2022 24.51 DKK 17.89%
2021 20.79 DKK 15.18%
2020 18.05 DKK 120.39%
2019 8.19 DKK 2.63%
2018 7.98 DKK -48.25%
2017 15.42 DKK 2.87%
2016 14.99 DKK 10.55%
2015 13.56 DKK 34.26%
2014 10.10 DKK 7.45%
2013 9.40 DKK 20.2%
2012 7.82 DKK 29.26%
2011 6.05 DKK 21.98%
2010 4.96 DKK 38.16%
2009 3.59 DKK 14.7%
2008 3.13 DKK 15.5%
2007 2.71 DKK 34.83%
2006 2.01 DKK 12.92%
2005 1.78 DKK 19.46%
2004 1.49 DKK 4.2%
2003 1.43 DKK 21.19%
2002 1.18 DKK 5.36%
2001 1.12 DKK 25.84%
2000 0.89 DKK 28.99%
1999 0.69 DKK 35.29%
1998 0.51 DKK -13.56%
1997 0.59 DKK 22.92%
1996 0.48 DKK 14.29%
1995 0.42 DKK 10.53%
1994 0.38 DKK 0.0%
1993 0.38 DKK 11.76%
1992 0.34 DKK 6.25%
1991 0.32 DKK 33.33%
1990 0.24 DKK 26.32%
1989 0.19 DKK -24.0%

Peer Eps Comparison of Novo Nordisk A/S

Name Eps Eps Difference
ALK-Abelló A/S 2.20 DKK -748.636%
Bavarian Nordic A/S 19.23 DKK 2.912%
Genmab A/S 66.64 DKK 71.984%
Gubra A/S -2.93 DKK 737.201%
Orphazyme A/S -0.74 DKK 2622.973%
Pharma Equity Group A/S -0.02 DKK 81985.965%
Zealand Pharma A/S -12.44 DKK 250.08%